Agomab Reports Half Year 2026 Financial Results and Confirms 2026 Outlook
Agomab Therapeutics today reported financial results for the half year period ended June 30, 2026, and confirmed its outlook for the second half of 2026.
Read the full story on GlobeNewswire → Opens the original article on www.globenewswire.comSummary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.